TH115893B - Pharmaceutical dosage form, capsule, consisting of an indolinone derivative suspension formulation. - Google Patents

Pharmaceutical dosage form, capsule, consisting of an indolinone derivative suspension formulation.

Info

Publication number
TH115893B
TH115893B TH901002518A TH0901002518A TH115893B TH 115893 B TH115893 B TH 115893B TH 901002518 A TH901002518 A TH 901002518A TH 0901002518 A TH0901002518 A TH 0901002518A TH 115893 B TH115893 B TH 115893B
Authority
TH
Thailand
Prior art keywords
capsule
dosage form
pharmaceutical dosage
suspension formulation
indolinone derivative
Prior art date
Application number
TH901002518A
Other languages
Thai (th)
Other versions
TH115893A (en
Inventor
นาย โธมัสบ็อค นาย รูดอล์ฟบินเดอร์ นาย โรมันเมสเซอร์ชมิด นาย เวอร์เนอร์บร็อกซ์
Original Assignee
เบอห์ริงเกอร์ อินเกลไฮม์ อินเตอร์เนชั่นแนล จีเอ็มบีเอช
Filing date
Publication date
Application filed by เบอห์ริงเกอร์ อินเกลไฮม์ อินเตอร์เนชั่นแนล จีเอ็มบีเอช filed Critical เบอห์ริงเกอร์ อินเกลไฮม์ อินเตอร์เนชั่นแนล จีเอ็มบีเอช
Publication of TH115893B publication Critical patent/TH115893B/en
Publication of TH115893A publication Critical patent/TH115893A/en

Links

TH901002518A 2009-06-05 A pharmaceutical dosage form of a capsule consisting of an indolinone derivative suspension formulation. TH115893A (en)

Publications (2)

Publication Number Publication Date
TH115893B true TH115893B (en) 2012-08-31
TH115893A TH115893A (en) 2012-08-31

Family

ID=

Similar Documents

Publication Publication Date Title
HRP20180709T1 (en) Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
CY2020008I2 (en) PHARMACEUTICAL FORMS OF DISTROMAT TABLET
BR112012011902A2 (en) pharmaceutical capsule
HK1259250A1 (en) Pharmaceutical formulations comprising 1-(beta-d-glucopyranosyl)-2-thienylmethylbenzene derivatives
DK2632493T3 (en) Drug Administration Compositions
FR2949470B1 (en) ANTICANCER DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
DK3045164T3 (en) Aqueous pharmaceutical compositions containing borate-polyol complexes
EP2429506A4 (en) Coated pharmaceutical capsule dosage form
DK3284467T3 (en) Nicotine-containing pharmaceutical compositions
BRPI1009324A2 (en) and / or pharmaceutically acceptable compounds thereof, pharmaceutical composition and their uses
BRPI1014027A2 (en) stable nanoparticle drug suspension.
FR2963007B1 (en) ANTICANCER DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2948568B1 (en) PHARMACEUTICAL FORMULATION
IL216113A (en) Substituted indazole and aza-indazole derivatives, pharmaceutical compositions comprising them and uses thereof
IT1404931B1 (en) OPHTHALMIC COMPOSITIONS FOR THE ADMINISTRATION OF LIPO-SOLUBLE ACTIVE PRINCIPLES.
BRPI1016190A2 (en) pharmaceutical compounds.
DK2391349T3 (en) Pharmaceutical composition comprising 2-oco-1-pyrrolidine derivatives
BR112012000831A2 (en) related compounds, pharmaceutical compositions and methods
DK2313087T4 (en) IMMEDIATE RELEASE PHARMACEUTICAL DOSAGE FORM OF AN INDOLINE DERIVATIVE
DK2391351T3 (en) Pharmaceutical composition comprising 2-oxo-1-pyrrolidine derivatives
BRPI0922653A2 (en) pharmaceutical preparation
EA201200616A1 (en) DERIVATIVES 2-OXO-1-PIRROLIDININILIMIDAZOTHIAADIA ASOL
IL233199B (en) Heterocyclic carboxamide derivatives, their preparation and pharmaceutical compositions containing them
CO6771413A2 (en) Diphenylamine derivatives: uses, synthesis procedure and pharmaceutical compositions
BR112013014606A2 (en) pharmaceutical compositions comprising alisporivir, their use, and capsule